Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma

Malignant melanoma is one of the untreatable cancers in which conventional therapeutic strategies, including chemotherapy, are hardly effective. Therefore, identification of novel therapeutic targets involved in melanoma progression is urgently needed for developing effective therapeutic methods. Ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Hayato, Yoshimatsu, Yasuhiro, Tomizawa, Taishi, Kunita, Akiko, Takayama, Rina, Morikawa, Teppei, Komura, Daisuke, Takahashi, Kazuki, Oshima, Tsukasa, Sato, Moegi, Komai, Mao, Podyma-Inoue, Katarzyna A., Uchida, Hiroaki, Hamada, Hirofumi, Fujiu, Katsuhito, Ishikawa, Shumpei, Fukayama, Masashi, Fukuhara, Takeshi, Watabe, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362032/
https://www.ncbi.nlm.nih.gov/pubmed/30718742
http://dx.doi.org/10.1038/s41598-019-39018-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362032/
https://www.ncbi.nlm.nih.gov/pubmed/30718742
http://dx.doi.org/10.1038/s41598-019-39018-3

Ejemplares similares